Global University Venturing

Sector analysis: Consumer

Quarterly analysis: Q1 2019

Special report: Chinese unicorns

Perspectives on sustainability and wellbeing are changing in response to health and environmental challenges, offering an opportunity to university-linked businesses.

Varian led a round for the targeted cancer drug developer that included existing investors such as Facit and Johnson & Johnson.

Sabic has equipped Mallinda with funding as the CU Boulder-founded thermoset resins provider gears up for the launch of its first commercial product.

Vector has received funding from UC-backed Congruent Ventures among others as it looks to enhance its software in supporting back office logistics functions.

NUI Maynooth spinout Avectas has added capital to converted equity previously supplied by therapeutics developer Adapt Pharma among others.

UVA’s seed fund and corporate venturing unit PharmStandard Ventures featured in topical dry eye syndrome peptide spinout TearSolutions' financing round, taking its total to $21.5m.

NovaUCD-based patient lingerie manufacturer Theya Healthcare has been backed by investors including Enterprise Ireland as it prepares for expansion in the US.

Bonsal will return to venture capital, ending a six-year spell as director of venture creation at Towson through which he was credited with the realignment of its incubator.